Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor. Flasch DA, Chen X, Ju B, Li X, et al. Acta Neuropathol 2022 Apr 11. pii: 10.1007/s00401-022-02420.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Flasch DA, Chen X, Ju B, Li X, et al. Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor. Acta Neuropathol 2022 Apr 11. pii: 10.1007/s00401-022-02420.
PMID: 35403869